Adverse Drug Events Reporting News

• Vitamins, OTC Drugs May Interact With HIV Antiretroviral Therapy OTC medications, food supplements, and other drugs may interact with antiretroviral therapy and harm people living with HIV, researchers in Denmark report.
  Medscape Medical News, May 20, 2022
• AYA Leukemia Survivors: 'Cure Is Not Enough' Adolescent and young adult (AYA) survivors of leukemia have a life span that is about 10% lower than that of their peers in the general population.
  Medscape Medical News, May 20, 2022
• Dopamine D1 Agonists May Aid Patients With Late-Stage Parkinson's The study covered in this summary was published on MedRxiv.org as a preprint and has not yet been peer reviewed.
  First Look, May 18, 2022
• AACE 2022 Biotin: Good for Hair and Nails, Bad for Thyroid Lab Tests New study supports prior finding that about 7% of the population uses products containing biotin in doses high enough to interfere with many laboratory tests, including those of thyroid function.
  Medscape Medical News, May 18, 2022
• Sarcopenia Nearly Doubles Risk Women Will Quit Endocrine Therapy But the good news is oncologists can address the condition before starting therapy. The study was published as a preprint and has not yet been peer reviewed.
  First Look, May 17, 2022
• CARRA 2022 Pfizer COVID Vax Performs Well in Youth With Rheumatic Diseases Nearly all participants in the study showed complete seroconversion, in contrast to similar studies in adults.
  Medscape Medical News, May 17, 2022
• Two Investigational Meds Promising for Myasthenia Gravis Two investigational medications are safe and effective for the treatment of generalized myasthenia gravis, new research shows.
  Medscape Medical News, May 16, 2022
• ACMS 2022 Bupivacaine Following Mohs Surgery Reduces Opioid Use Patients report lower pain and opioid use with a single injection of the local anesthetic compared with placebo.
  Medscape Medical News, May 16, 2022
• Alert FDA Approves Oral Form of ALS Drug Edaravone The FDA has approved an orally administered version of edaravone for adults with amyotrophic lateral sclerosis.
  FDA Approvals, May 13, 2022
• Stimulants Plus Buprenorphine for OUD a Double-Edge Sword? Stimulants may lead to better engagement in buprenorphine treatment at the cost of a modest increase in drug overdose risk in patients with opioid addiction.
  Medscape Medical News, May 12, 2022
• AGS 2022 Cannabis-Related ED Visits Up 18-fold for Older Californians Researchers say more work needs to be done to explain why the rate of marijuana-related emergencies skyrocketed among older adults from 2005 to 2019.
  Medscape Medical News, May 12, 2022
• Safety of COVID-19 Vaccine a Concern for Pregnant Women A Canadian survey suggests that safety is an important question for pregnant women who accept the COVID-19 vaccine and for those who do not.
  Medscape Medical News, May 12, 2022
• CAR-T Outcomes Similar Among Black, Hispanic, White, Asian Patients Black and Hispanic cancer patients who underwent CAR-T therapy at a single center had comparable outcomes to their white and Asian counterparts, researchers say.
  Reuters Health Information, May 10, 2022
• Breast Cancer Test Recommended for Extended Endocrine Therapy The Breast Cancer Index is the only genomic test that should be used to guide extended endocrine therapy decisions for women with early-stage, hormone receptor–positive breast cancer, says ASCO.
  Medscape Medical News, May 10, 2022
• Journal Retracts Cesarean Delivery Paper With 'Impossible' Data The study purported to involve nearly 1300 women – making it the largest analysis of women receiving steroids for the indication in the trial.
  Retraction Watch, May 09, 2022
• Which Surgical Approach Is Best for Pelvic Prolapse? Transvaginal mesh matched native tissue repair of pelvic organ prolapse for some outcomes in a three-year trial.
  Medscape Medical News, May 06, 2022
• AANS 2022 Collagen 'Tile' Delivers Postsurgical Radiation in Glioblastoma Following tumor removal, an absorbable collagen tile delivers a controlled and therapeutic dose of radiation targeting remaining tumor cells and sparing healthy tissue, new research suggests.
  Medscape Medical News, May 06, 2022
• Vagus Nerve Stimulation: A Little-Known Option for Depression The treatment, which is less well known than electroconvulsive therapy, appears to provide additional benefit when administered with standard antidepressant therapy.
  Medscape Medical News, May 05, 2022
• The Uphill Struggle for High-Intensity Statins in ASCVD Patients A national study uncovered abysmal rates of usage for one of the most studied and inexpensive therapies available.
  Medscape Medical News, May 03, 2022
• Study Provides New Data on Isotretinoin and Psychiatric Effects Although severe neuropsychiatric effects associated with isotretinoin therapy in patients with acne have been reported, 'the evidence base…is mixed and inconclusive,' according to the authors of a new study.
  Medscape Medical News, May 02, 2022